EW Healthcare Partners overview
Stories about EW Healthcare Partners
Cognate acquires Cobra Biologics
Cognate BioServices has acquired UK and Sweden-based Cobra Biologics, an advanced therapy CDMO that specializes in providing manufacturing services for the plasmid DNA and viral vector. No financial terms were disclosed. Cognate's backers include EW Healthcare Partners.

EW Healthcare Partners raises $746.33m
The Houston-based growth equity firm closed its latest healthcare technology fund.
EW Healthcare invests in Cognate BioServices
EW Healthcare Partners has invested in Cognate BioServices. Financial terms weren’t announced. Cognate BioServices is a contract development and manufacturing organization.
EW Healthcare Partners racks up $745 mln for fund
EW Healthcare Partners has raised $745 million for its second growth equity fund, beating its $650 million target. Fund2a targets healthcare companies in the pharmaceutical, medical device, diagnostics and technology-enabled services sectors in the U.S. and in Europe.
TissueTech snags $82.25 mln
Miami-based TissueTech Inc, a provider of therapeutic solutions for the ocular surface, wounds, surgery and other applications, has raised $82.25 million in financing. EW Healthcare Partners led the round.
Venus Concept gathers $38 mln
Toronto-based Venus Concept Ltd, an aesthetic technology company, has secured $38 million in funding. EW Healthcare Partners led the round with participation from HealthQuest Capital and Madryn Asset Management.

Aesthetic tech provider Venus Concept wins $48 mln in funding
Toronto aesthetic technology company Venus Concept Ltd has raised $38 million in an equity investment. The transaction was led by EW Healthcare Partners and joined by HealthQuest Capital and Madryn Asset Management. As a result, EW Healthcare and HealthQuest will each receive one seat on the board. Founded in 2009, Venus Concept develops and makes non-invasive devices for the global medical aesthetics market. Led by CEO Domenic Serafino, it will use the funds raised to grow its subscription-based business model and continue to develop its products. The company secured $10 million /canada/2014/5/venus-concept-nets-10-mln-in-funding-from-longitude-capital/ from Longitude Capital in 2014.
EW Healthcare Partners contact information
Offices
Contacts
| Name | Job title | Location | |
|---|---|---|---|
| Key Contact | Job titleInvestor Relations Professional | LocationHouston, United States | Email |
Job titleChief Operating Officer and Managing Director | LocationNew York, United States | Email | |
Job titleChief Financial Officer and Chief Compliance Officer | LocationHouston, United States | Email | |
Job titleChief Executive Officer and Managing Director | LocationLondon, United Kingdom | Email | |
EW Healthcare Partners funds managed
Closed funds: 11
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size | Close dateJan 2021 | Strategy | |
Fund size | Close dateAug 2019 | Strategy | |
Fund size | Close dateOct 2016 | Strategy | |
Stories that mention EW Healthcare Partners
NY-based Invidia Capital Management adds third partner in two months
Until July, the healthcare-focused firm’s sole partner was its founder, the former global head of healthcare private investing at Goldman Sachs
Grooming tech to keep hospitals clean
A bevy of start-ups in recent years have emerged to help disinfect all aspects of hospitals, from handwashing to patient rooms to healthcare devices. This seemed like a novel idea before covid-19, but it’s essential now.
Cognate Bioservices takes in Series B, also buys Cobra Biologics
Cognate Bioservices, a contract development and manufacturing organization specializing in cell and cell-mediated gene therapy products, has closed its Series B funding round.
Dental tech company rakes in $85 mln
Sonendo, a dental tech company, has secured $85 million in funding.
Encore Dermatology secures $20 mln from Horizon
Horizon has provided a $20 million venture loan facility to Encore Dermatology. Headquartered in Malvern, Pennsylvania, Encore Dermatology is a specialty dermatology company. Encore is backed by EW Healthcare Partners, 1315 Capital and Longitude Capital.
Cota attracts $40 mln Series C
New York City-based Cota Inc, a healthcare real-world evidence and data analytics company, has raised $40 million in Series C financing. IQVIA led the round with participation from other investors that included EW Healthcare Partners.
Venture-backed Venus Concept to buy NeoGraft Solutions
Toronto-based aesthetic technology company Venus Concept Ltd has agreed to buy the hair restoration business of Lewisville, Texas-based NeoGraft Solutions. No financial terms were disclosed for the deal, which is expected to close this month. Venus Concept said the acquisition will broaden its customer base and product portfolio and spur growth plans for 2018. Founded in 2009, Venus Concept last year raised about $48 million in a financing /canada/2017/07/3462602/ led by EW Healthcare Partners and joined by HealthQuest Capital and Madryn Asset Management. It is also backed by Longitude Capital.